RxDoctor Payments Data

Carty-Anna Patrice

Physician Assistant · El Paso, TXNPI 1851309371

Payments from drug & device makers

$1,521in general payments, 2019–2025

Across 85 payments — averaging $17.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$260
  • Abbott$213
  • GSK$154
  • Lilly USA, LLC$128
  • Johnson & Johnson$121
  • Novo Nordisk$109
  • plus $536 from 13 others

What the payments were for

  • Food & beverage$1,521100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,521 in reported general payments places this provider in the 70th percentile of 8,308 physician assistant providers in Texas.

See all physician assistant providers in Texas

Medicare billing

Part B allowed, 2024
$11,897
Medicare patients
35
Services billed
303

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol53$74,472
TrulicityDulaglutide17$39,135
MounjaroTirzepatide25$31,608
JanuviaSitagliptin Phosphate13$15,172
Tresiba Flextouch U-200Insulin Degludec11$12,841
ArexvyRsvpref3 Antigen/As01e/Pf33$10,459
DapagliflozinDapagliflozin Propanediol11$8,775
ShingrixVaricella-Zoster Ge/As01b/Pf14$3,135
Omega-3 Acid Ethyl Esters11$2,159
Oxybutynin Chloride ErOxybutynin Chloride35$1,980
Lantus SolostarInsulin Glargine,hum.Rec.Anlog18$1,973
Atorvastatin Calcium168$1,220
Losartan Potassium81$1,016
Famotidine65$931
Omeprazole41$891

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga$260$74,47253 claims
Lilly USA, LLCTrulicity, Mounjaro$128$70,74342 claims
MerckJanuvia$34$15,17213 claims
GSKArexvy, Shingrix$154$13,59447 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 8,308 physician assistant providers in Texas.

Other physician assistant in El Paso

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →